BATS BZX Real-Time Price
As of 10:26am ET
| -1.20 / -6.79%|
The 7 analysts offering 12-month price forecasts for NxStage Medical Inc have a median target of 24.00, with a high estimate of 30.00 and a low estimate of 15.00. The median estimate represents a +45.72% increase from the last price of 16.47.
The current consensus among 9 polled investment analysts is to Buy stock in NxStage Medical Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.